20+ years experience in finance, including M&A, and multiple IPOs, integration of pharmaceutical operations (Whitehall Robbins, Rhone Polenc, Boehringer, Aventis)
Founder of Merus Labs (NASDAZ: MSLI), sold for $300 M+ in 2017
Acquisition, integration, tech transfer and management of branded pharmaceutical products Enablex®/Emselex®, Entrophen®, Sandomigran®, Sintrom®, Vancocin®, Zaditen®
